Previous Page  268 / 1816 Next Page
Information
Show Menu
Previous Page 268 / 1816 Next Page
Page Background

Ohsumi S, et al. Breast Cancer Res Treat. 2011;127:143–152

Continuation of tamoxifen treatment after

adjuvant tamoxifen for 1–4 years may provide

Japanese breast cancer patients with better

HRQOL than by switching to anastrozole.

Side effects

Less local treatment: discussion